# Vir Biotechnology, Inc.: Form 8-K, filed Oct 1, 2026

- Company: [Vir Biotechnology, Inc.](/companies/vir.md) (CIK 1706431)
- Form: 8-K
- Filed: 2026-10-01
- Accepted by EDGAR: Oct 1, 2026, 08:34 ET
- Period: 2026-10-01
- Accession: 0001628280-26-064117
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1706431/000162828026064117/vir-20261001.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1706431/000162828026064117/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1706431/000162828026064117/vir-20261001.htm

Filed Oct 1, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-064117. Last ingested by Listed: Nov 3, 2026, 11:08 ET. No prices; not investment advice.